Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network

Kario, Kazuomi and Hoshide, Satoshi and Chia, Yook-Chin and Buranakitjaroen, Peera and Siddique, Saulat and Shin, Jinho and Turana, Yuda and Park, Sungha and Tsoi, Kelvin and Chen, Chen-Huan and Cheng, Hao-Min and Fujiwara, Takeshi and Li, Yan and Huynh, Van Minh and Nagai, Michiaki and Nailes, Jennifer and Sison, Jorge and Soenarta, Arieska Ann and Sogunuru, Guru Prasad and Sukonthasarn, Apichard and Tay, Jam Chin and Teo, Boon Wee and Verma, Narsingh and Wang, Tzung-Dau and Zhang, Yuqing and Wang, Ji-Guang (2021) Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network. Journal of Clinical Hypertension, 23 (3, SI). pp. 411-421. ISSN 1524-6175, DOI

Full text not available from this repository.


Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia.

Item Type: Article
Funders: Pfizer
Uncontrolled Keywords: Ambulatory blood pressure monitoring;Blood pressure control; Clinical practice;Guidelines;Hypertension
Subjects: R Medicine
Divisions: Faculty of Medicine
Depositing User: Ms Zaharah Ramly
Date Deposited: 30 May 2022 07:52
Last Modified: 30 May 2022 07:52

Actions (login required)

View Item View Item